| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/11/2001 | US6287817 Administering fusion protein of single chain fv molecule against transcytotic receptor linked to therapeutic protein; delivers protein to epithelial cell; treatment of cystic fibrosis |
| 09/11/2001 | US6287816 BMP-9 compositions |
| 09/11/2001 | US6287814 RNA export element and methods of use |
| 09/11/2001 | US6287813 Host cell has nucleotide sequence linked to eukaryotic promoter and pabr sequence, and also nucleic acid coding for polypeptide that binds to sequence in absence of antibiotic; protein production, tissue engineering, gene therapy |
| 09/11/2001 | US6287812 Polynucleotide encoding a specific amino acid sequence; diagnostic probes; anticarcinogenic therapy against breast cancer and leukemia |
| 09/11/2001 | US6287810 Nucleotide sequence; diagnosis; probes; primers; drug screening; bactericides; vaccines |
| 09/11/2001 | US6287809 Mutant rex transdominant repressors of HIV replication |
| 09/11/2001 | US6287808 Nucleotide and amino acid sequences; fusion proteins; antigenic peptides; antibodies; diagnosis, screening, and therapy of related disorders such as inflammatory bowel disease and asthma; viricides; antiinflammatory agents |
| 09/11/2001 | US6287806 Method for producing a biologically active recombinant cysteine-free peptide |
| 09/11/2001 | US6287805 Amino acid sequence of chemokine receptor; diagnosis of related diseases; drug screening; antiinflammatory agents; probes; primers; antisense agents |
| 09/11/2001 | US6287804 nrdG |
| 09/11/2001 | US6287803 Polynucleotides encoding a novel era polypeptide |
| 09/11/2001 | US6287802 EXT2 gene |
| 09/11/2001 | US6287801 Nucleic acids encoding the G-protein coupled receptor HNFDS78 |
| 09/11/2001 | US6287795 Mch4 and Mch5, apoptotic protease, nucleic acids encoding and methods of use |
| 09/11/2001 | US6287792 Drug delivery of antisense oligonucleotides and peptides to tissues in vivo and to cells using avidin-biotin technology |
| 09/11/2001 | US6287788 The neuropeptide galanin and its receptors hold great promise as targets for the development of novel therapeutic agents. |
| 09/11/2001 | US6287786 Nucleic acid molecules encoding a new mammalian protein and to the use of these molecules in the characterization, diagnosis, and treatment of conditions such as disorders associated with cell proliferation, lipid metabolism and transport. |
| 09/11/2001 | US6287785 Homogenous enzyme immunoassay process |
| 09/11/2001 | US6287777 Several genes expressed differentially between the human prostate carcinoma cell lines lncap and pc-3, which are androgen-dependent and androgen-independent, respectively, have now been isolated. one of these genes, designated npg-1. |
| 09/11/2001 | US6287776 Method for detecting and classifying nucleic acid hybridization |
| 09/11/2001 | US6287773 Profile searching in nucleic acid sequences using the fast fourier transformation |
| 09/11/2001 | US6287771 The method is quick and accurate and avoids the need for excising mammary gland tissue. |
| 09/11/2001 | US6287770 Nucleic acid promoters |
| 09/11/2001 | US6287769 Simultaneous applying a polymerase chain reaction to dna with each primer obtained and analyzed to have an electrophoretic pattern at optimum amplification probability; analyzing contaminants in soil, food, or organic matter; composting |
| 09/11/2001 | US6287768 Polymeric arrays and methods for their use in binding assays |
| 09/11/2001 | US6287766 Comprising immobilization of annealable oligonucleotide next to base whose identity is to be determined on microsphere; incubating with labeled dideoxynucleotides, binding tagged primers and measuring fluorescence |
| 09/11/2001 | US6287764 Class I sequence based typing of HLA-A, -B, and -C alleles by direct DNA sequencing |
| 09/11/2001 | US6287762 Purification of a triple helix formation with an immobilized oligonucleotide |
| 09/11/2001 | US6287760 Western blot test for the identification of antibodies specific against the HCMV virus |
| 09/11/2001 | US6287759 Recombinant proteins of a Pakistani strain of hepatitis E and their use in diagnostic methods and vaccines |
| 09/11/2001 | US6287756 Methods for determining presence of cancer in a sample by determining expression of an SSX gene |
| 09/11/2001 | US6287711 Wear-resistant coating and component |
| 09/11/2001 | US6287580 Activated by air and moisture |
| 09/11/2001 | US6287574 Proteinase K resistant surface protein of neisseria meningitidis |
| 09/11/2001 | US6287572 Genetic engineering |
| 09/11/2001 | US6287571 Replication-defective adenovirus human type 5 recombinant as a vaccine carrier |
| 09/11/2001 | US6287569 Vaccines with enhanced intracellular processing |
| 09/11/2001 | US6287559 Cloning and recombinant production of vespid venom hyaluronidases, and immunological therapies based thereon |
| 09/11/2001 | US6287557 Methods of gene therapy using herpes viral vectors expressing GM-CSF |
| 09/11/2001 | US6287556 Intracellular delivery vehicles |
| 09/11/2001 | US6287554 Chicken interleukin-15 and uses thereof |
| 09/11/2001 | CA2176205C Osteogenic product and process |
| 09/11/2001 | CA2166889C Oligonucleotides with activity against human immunodeficiency virus |
| 09/11/2001 | CA2125175C New peptide derivatives |
| 09/11/2001 | CA2056005C Thrombin-binding substance and process for preparing the same |
| 09/11/2001 | CA2021528C Muteins of human erythropoietin, the preparation thereof and the use thereof |
| 09/11/2001 | CA1341290C Method of genetically modifying plants |
| 09/07/2001 | WO2001065509A2 Cellular telephone interactive wagering system |
| 09/07/2001 | WO2001065262A2 Reagents and methods useful for detecting diseases of the breast |
| 09/07/2001 | WO2001065256A1 A method for detecting the reactivity of lymphocyte in blood to a specific antigen |
| 09/07/2001 | WO2001065252A1 Transgenic mice comprising a genomic human tau transgene |
| 09/07/2001 | WO2001065249A1 Apparatus and method for correcting frame shift error of cdna sequence, and recorded medium on which program for executing the method is recorded |
| 09/07/2001 | WO2001064958A2 Modified oligonucleotides for mismatch discrimination |
| 09/07/2001 | WO2001064956A2 The identification and use of effectors and allosteric molecules for the alteration of gene expression |
| 09/07/2001 | WO2001064955A1 Antisense modulation of parp expression |
| 09/07/2001 | WO2001064954A1 Method of reverse transcription using bacillus steraothermophilus or thermoactinomyces vulgaris dna polymerase |
| 09/07/2001 | WO2001064952A2 Method for reducing artifacts in nucleic acid amplification |
| 09/07/2001 | WO2001064949A2 Diagnostics and therapeutics for glaucoma |
| 09/07/2001 | WO2001064948A1 Universal variable fragments |
| 09/07/2001 | WO2001064946A1 Method of detecting chronic myelogenous leukemia |
| 09/07/2001 | WO2001064945A2 Novel dna chips |
| 09/07/2001 | WO2001064944A1 MODULATION OF PLEIOTROPHIN SIGNALING BY RECEPTOR-TYPE PROTEIN TYROSINE PHOSPHATASE β/$g(z) |
| 09/07/2001 | WO2001064942A1 Protein scaffolds for antibody mimics and other binding proteins |
| 09/07/2001 | WO2001064930A1 Protein hollow nano particles, transporter with the use of the same and method of introducing substance into cells |
| 09/07/2001 | WO2001064929A1 Production of antibodies in transgenic plastids |
| 09/07/2001 | WO2001064928A2 Transgenic plants with increased seed yield, biomass and harvest index |
| 09/07/2001 | WO2001064927A1 Expression of an antimicrobial peptide via the plastid genome to control phytopathogenic bacteria |
| 09/07/2001 | WO2001064926A2 Methods and compositions to reduce or eliminate transmission of a transgene |
| 09/07/2001 | WO2001064925A1 Transformation of eukaryotic cells by mobilizable plasmids |
| 09/07/2001 | WO2001064924A1 Embryo sac-specific genes |
| 09/07/2001 | WO2001064923A2 Vire2-mediated trans-membrane delivery systems |
| 09/07/2001 | WO2001064922A2 Heterologous expression of neisserial proteins |
| 09/07/2001 | WO2001064921A1 Melanoma differentiation associated gene - 7 promoter and uses thereof |
| 09/07/2001 | WO2001064920A2 Hybrid expression of neisserial proteins |
| 09/07/2001 | WO2001064919A2 18036, a novel calpain-like protease and uses thereof |
| 09/07/2001 | WO2001064918A1 Novel polypeptide---human nuclear translocator protein 12 containing atp/gtp binding domain and polynucleotide encoding it |
| 09/07/2001 | WO2001064917A1 Novel polypeptide---a human signal transduction protein kinase 11 and polynucleotide encoding it |
| 09/07/2001 | WO2001064916A1 Novel polypeptide---human excitatory amino acid transporter protein 9 and polynucleotide encoding it |
| 09/07/2001 | WO2001064915A1 Novel polypeptide---the factor 1-25 being homology with human fibroblast growth factor and polynucleotide encoding it |
| 09/07/2001 | WO2001064914A1 Method for producing a recombinant alpha-galactosidase of thermus sp. t2 in host cells |
| 09/07/2001 | WO2001064913A2 Cell cycle proteins associated with rad9, compositions and methods of use |
| 09/07/2001 | WO2001064912A2 Triazine degrading enzymes |
| 09/07/2001 | WO2001064911A2 18232, a dual specificity phosphatase |
| 09/07/2001 | WO2001064910A2 Atpase-like molecule and uses thereof |
| 09/07/2001 | WO2001064909A1 Dna polymerase mu and uses thereof |
| 09/07/2001 | WO2001064908A2 14790, a protein kinase and uses therefor |
| 09/07/2001 | WO2001064907A2 Lipid metabolism enzymes |
| 09/07/2001 | WO2001064906A1 Transferase 32253 and use therefor |
| 09/07/2001 | WO2001064905A2 2504, 15977, and 14760, novel protein kinase family members and uses therefor |
| 09/07/2001 | WO2001064904A2 25324, 50287, 28899, 47007, and 42967 transferase family members and uses therefor |
| 09/07/2001 | WO2001064903A2 Novel human transferase proteins and polynucleotides encoding the same |
| 09/07/2001 | WO2001064902A2 46867, a transferase family member and uses therefor |
| 09/07/2001 | WO2001064901A1 Beta 1, 2-xylosyltransferase-gene from arabidopsis |
| 09/07/2001 | WO2001064900A2 Aspartate carbamyltransferase as herbicidal target |
| 09/07/2001 | WO2001064899A2 Nucleotide sequences encoding proteins that take part in the biosynthesis of l-serine, improved method for microbially producing l-serine, and genetically modified microorganism suitable for use in said method |
| 09/07/2001 | WO2001064898A2 Genes encoding denitrification enzymes |
| 09/07/2001 | WO2001064897A2 Mutant bacterial strains of the genus sphingonomas deficient in production of polyhydroxybutyrate and process of clarification of sphingans |
| 09/07/2001 | WO2001064896A2 Human enzyme molecules |
| 09/07/2001 | WO2001064891A2 Nucleotide sequences for embryo and/or endosperm specific expression in plants |